Human cell engraftment after busulfan or irradiation conditioning of NOD/SCID mice

Haematologica

Volumn 91, Issue 10, 2006, Pages 1384-1387

  Robert Richard, Elodie ^a,b   Ged, Cécile ^a,b   Ortet, Jacqueline ^c   Santarelli, Xavier ^b   Lamrissi Garcia, Isabelle ^a,b   De Verneuil, Hubert ^a,b   Mazurier, Frédéric ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Busulfan; Conditioning; NOD SCID; SCID repopulating cell assay; Transplantation

Indexed keywords

BUSULFAN;

ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG EFFICACY; HEMATOPOIETIC STEM CELL; IRRADIATION; MOUSE; NONHUMAN; STEM CELL TRANSPLANTATION; XENOGRAFT;

EID: 33750003893     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dick JE, Bhatia M, Gan O, Kapp U, Wang JC. Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells 1997;15 Suppl 1:199-203.
2. Mazurier E Fontanellas A. Salesse S. Taine L, Landriau S, Moreau-Gaudry F, et al. A novel immunodeficient mouse model: RAG2 x common cytokine receptor γ chain double mutants-requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J Interferon Cytokine Res 1999;19:533-41.
3. Kollet O, Peled A, Byk T, Greiner D, Shultz L. Lapidot T. β2 microglobulin-deficient (β2m (null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 2000;95:3102-5.
4. c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100:3175-3182.
5. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {Γ} chain(null) mice. Blood 2005; 106:1565-73.
6. Minamiguchi H, Wingard JR, Laver JH, Mainali ES, Shultz LD, Ogawa M. An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice. Biol Blood Marrow Transplant 2005;11:487-94.
7. +)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997;90:85-96.
8. + cells. Exp Hematol 2003;31:551-8.
9. + cells. Blood 2005;106:1259-61.
10. Mauch P, Down JD, Warhol M, Hellman S. Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan. Transplantation 1988;46:205-10.
11. Down JD, Ploemacher RE. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. Exp Hematol 1993;21:913-21.
12. Neben S, Hellman S, Montgomery M, Ferrara J, Mauch P. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol 1993;21:156-62.
13. Yeager AM, Shinn C, Farmer ER, Wingard JR, Yeager MJ. Growth retardation and depigmentation of hair after high-dose busulfan and congenic hematopoietic cell transplantation in mice. Bone Marrow Transplant 1992;9:199-204.
14. Askenasy N, Farkas DL. Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo. Stem Cells 2002; 20:501-13.
15. Ishikawa F, Livingston AG, Wingard JR, Nishikawa S, Ogawa M. An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/β2-microglobulin(null) mice. Exp Hematol 2002;30:488-94.
16. Tanaka T, Tsudo M, Karasuyama H, et al. A novel monoclonal antibody against murine IL-2 receptor β-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J Immunol 1991;147:2222-8.
17. Mazurier F, Gan OI, McKenzie JL, Doedens M, Dick JE. Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 2004;103:545-52.
18. Nguyen L, Leger F. Lennon S, Puozzo C. Intravenous busulran in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study. Cancer Chemother Pharmacol 2006;57:191-8.
19. Mazurier F, Doedens M, Gan OI, Dick JE. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat MeD 2003;9:959-963.
20. Glimm H, Eisterer W, Lee K, Cashman J, Holyoake TL, Nicolini F, et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest 2001; 107:199-206.
21. Yahata T, Ando K, Sato T, Miyatake H, Nakamura Y, Muguruma Y, et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection or primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003;101:2905-13.
22. Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y. et al. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood 2003;101:2924-31.